Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEcofin U.s. $ Regulatory News (RNEW)

Share Price Information for Ecofin U.s. $ (RNEW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.5275
Bid: 0.505
Ask: 0.55
Change: 0.00 (0.00%)
Spread: 0.045 (8.911%)
Open: 0.52
High: 0.5275
Low: 0.52
Prev. Close: 0.5275
RNEW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q4 2023 Net Asset Value

13 Feb 2024 16:39

RNS Number : 0213D
Ecofin US Renewables Infrastr.Trust
13 February 2024

13 February 2024

ECOFIN U.S. RENEWABLES INFRASTRUCTURE TRUST PLC

(the "Company")

Q4 2023 Net Asset Value

Ecofin U.S. Renewables Infrastructure Trust PLC announces that its unaudited net asset value ("NAV") as at 31 December 2023 on a cum-income basis was $0.8521 per Ordinary Share (30 September 2023: $0.8910) or $117.7 million (30 September 2023: $123.0 million).

The key contributors to the changes in NAV were:

· a $1.3 million decrease ($0.0097 per Ordinary Share) in fair market value of investments due to the expected quarterly roll-off of distributable cash flows in the forward-looking discounted cash flow models. In accordance with the International Private Equity and Venture Capital Valuation (IPEV) Guidelines, the Company continued to apply a discounted cash flow ("DCF") valuation methodology for valuing the privately owned operating renewable assets in its portfolio. The valuation was performed by an independent third-party valuation firm, Marshall & Stevens; and

· a $3.7 million decrease ($0.0270 per Ordinary Share) in cash and accrued financial assets as quarterly income did not cover operating expenses, financing costs and dividend payments, primarily driven by lack of revenue at Whirlwind, slower than expected insurance claim proceeds related to Whirlwind, high corrective O&M costs at several solar sites, and increased insurance premiums across the portfolio.

As part of the Strategic Review announced on 8 September 2023 (RNS Number: 7853L), Marathon Capital ("Marathon") is acting as financial adviser in relation to a potential sale process for the Company's assets which, if successful, would result in an expected return of cash to shareholders, in connection with a winding up of the Company or similar transaction. The Company and Marathon continue to make progress and the Board will make further announcements when appropriate.

There can be no certainty as to the outcome of the Strategic Review or any asset sale process, nor whether any potential transaction or transactions arising could be successfully completed or the valuation at which it or they could be completed. In addition, should a transaction arise that would involve the sale of the Company's assets, it is expected that the implementation of such transaction will be conditional upon shareholder approval at a general meeting of the Company.

For further information, please contact:

Ecofin Advisors, LLC (Investment Manager)

Edward Russell

Eileen Fargis

Michael Hart

+1 913 981 1020

Stifel (Corporate Broker)

Edward Gibson-Watt

Rajpal Padam

Madison Kominski

+44 20 7710 7600

Apex Listed Companies Services (UK) Limited (Company Secretary)

Martin Darragh

+44 20 3327 9720

Further information on the Company can be found on its website at https://uk.ecofininvest.com/funds/us-renewables-infrastructure-trust-plc/.

The Company's LEI is 2138004JUQUL9VKQWD21.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NAVSFWFMDELSEDE
Date   Source Headline
31st Jan 20237:00 amRNSNet Asset Value(s)
27th Jan 20234:00 pmRNSQuotedData's Weekly News & Interview
26th Jan 202311:30 amRNSUpdate research from QuotedData
19th Jan 20234:12 pmRNSHolding(s) in Company
17th Jan 20237:00 amRNSName Change of Administrator and Company Secretary
14th Dec 202211:13 amRNSDirector/PDMR Shareholding
13th Dec 20223:59 pmRNSDirector/PDMR Shareholding
15th Nov 202211:10 amRNSExchange rate for interim dividend
2nd Nov 20227:00 amRNSPurchase of Management Fee Shares
31st Oct 20227:00 amRNSNet Asset Value(s)
31st Oct 20227:00 amRNSDividend Declaration
31st Oct 20227:00 amRNSQuarterly Factsheet as at 30 September 2022
24th Oct 20227:00 amRNSAppointment of Managing Director and Group Lead
16th Sep 20227:00 amRNSHalf-year Report
14th Sep 20225:16 pmRNSDirector/PDMR Shareholding
14th Sep 202212:36 pmRNSDirector/PDMR Shareholding
17th Aug 202210:04 amRNSExchange rate for interim dividend
1st Aug 20227:00 amRNSTotal Voting Rights
28th Jul 20227:00 amRNSNet Asset Value(s)
28th Jul 20227:00 amRNSDividend Declaration
28th Jul 20227:00 amRNSQuarterly Factsheet as at 30 June 2022
28th Jul 20227:00 amRNSIssue of Management Fee Shares
19th Jul 20227:00 amRNSInvestment Management Update
15th Jul 20224:18 pmRNSHolding(s) in Company
12th Jul 20224:46 pmRNSDirector/PDMR Shareholding
12th Jul 20224:45 pmRNSDirector/PDMR Shareholding
22nd Jun 20224:57 pmRNSResult of AGM
22nd Jun 20227:00 amRNSAGM Update
1st Jun 20227:00 amRNSTotal Voting Rights
30th May 20222:11 pmRNSExchange rate for the interim dividend
24th May 20223:48 pmRNSDirector/PDMR Shareholding
20th May 20227:00 amRNSResults of Placing and REX Retail Offer
10th May 20227:01 amRNSREX Retail Offer
10th May 20227:00 amRNSLaunch of Placing to fund near-term pipeline
3rd May 20223:15 pmRNSTotal Voting Rights
29th Apr 202212:38 pmRNSDirector Declaration
28th Apr 20227:05 amRNSIssue of Equity
28th Apr 20227:02 amRNSDividend Declaration
28th Apr 20227:00 amRNSNet Asset Value(s)
19th Apr 20227:00 amRNSAnnual Financial Report
13th Apr 202212:17 pmRNSDirector/PDMR Shareholding
13th Apr 202211:41 amRNSDirector/PDMR Shareholding
4th Apr 20227:00 amRNSAppointment of Joint Broker
25th Mar 202212:41 pmRNSResearch from QuotedData
11th Mar 20227:00 amRNSNet Asset Value at 31 December 2021
1st Mar 202212:54 pmRNSExchange rate for Interim dividend
31st Jan 20222:38 pmRNSPurchase of Management Fee Shares
27th Jan 20227:00 amRNSInterim Dividend Declaration and Quarterly NAV
16th Dec 20217:00 amRNSDirector/PDMR Shareholding
6th Dec 20214:56 pmRNSChange of Registered Office

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.